Literature DB >> 32667978

Treatment of Coronavirus Disease 2019-Evidence-based or Personalized Medicine?

Ferric C Fang1, Robert T Schooley2.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; clinical trials; evidence-based medicine; personalized medicine

Mesh：

Substances：

Year:  2022        PMID： 32667978      PMCID： PMC7454443          DOI： 10.1093/cid/ciaa996

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations.

Authors:  Bo Ning; Brady M Youngquist; Diane D Li; Christopher J Lyon; Adrian Zelazny; Nicholas J Maness; Di Tian; Tony Y Hu
Journal:  Cell Rep Methods       Date:  2022-02-07

Review 2.  In vitro high-content tissue models to address precision medicine challenges.

Authors:  Samson Afewerki; Thiago Domingues Stocco; André Diniz Rosa da Silva; André Sales Aguiar Furtado; Gustavo Fernandes de Sousa; Guillermo U Ruiz-Esparza; Thomas J Webster; Fernanda R Marciano; Maria Strømme; Yu Shrike Zhang; Anderson Oliveira Lobo
Journal:  Mol Aspects Med       Date:  2022-08-17

3.  Bio-ethical issues in oncology during the first wave of the COVID-19 epidemic: A qualitative study in a French hospital.

Authors:  Henri-Corto Stoeklé; Laure Ladrat; Terence Landrin; Philippe Beuzeboc; Christian Hervé
Journal:  J Eval Clin Pract       Date:  2022-09-15       Impact factor: 2.336
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.